Compare Plby Group Inc (PLBY) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plby Group Inc vs Tilray Brands Inc — how do they compare? Plby Group Inc trades at $0.98 (market cap $118.21M), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: Tilray Brands Inc is far larger — about 4.5× Plby Group Inc's market cap, and Plby Group Inc is more actively traded (919,783 versus 9,099,075). Which is the better fit depends on your goals — on Pluang, investors hold Plby Group Inc for 24 Days and Tilray Brands Inc for 31 Days on average.
| PLBY | TLRY | |
|---|---|---|
Market Cap | $118.21M | $530.54M |
Volume | 919,783 | 9,099,075 |
Sector | Consumer Cyclical | Health |
52-Week High | $2.71 | $17.20 |
52-Week Low | $0.98 | $3.54 |
Typical Hold Time | 24 Days | 31 Days |
Enterprise Value | $263.80M | $684.46M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PLBY trades at $0.9867, down 3.26% today, amid a bearish technical signal with selling pressure across moving averages. The company reported Q2 2026 EPS of $0.00173, beating expectations, and revenue of $121 million in 2025, with net losses narrowing to $12.67 million. Recent news highlights leadership appointments aimed at driving brand growth. Analyst consensus is 75% buy, but high debt and negative equity pose fundamental risks.
Outlook remains cautious due to persistent losses and leveraged balance sheet, though cost controls and licensing growth offer potential upside. Key risks include execution on profitability, competitive pressures, and sensitivity to consumer spending. Investors should weigh analyst optimism against structural financial challenges.
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
